혈행동태 모니터링 시스템 시장 규모 조사 및 예측 : 시스템별, 용도별, 지역별 분석(2023-2030년)

Global Hemodynamic Monitoring System Market is valued at approximately USD 1.20 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 3.58% over the forecast period 2023-2030. Hemodynamic monitoring systems are medical devices designed to measure and assess the dynamics of blood flow and pressure within the cardiovascular system. These systems provide clinicians with real-time data on key hemodynamic parameters such as blood pressure, cardiac output, and fluid status, enabling them to evaluate cardiovascular function and guide therapeutic interventions. Hemodynamic monitoring is crucial in various clinical settings, including intensive care units, operating rooms, and cardiac catheterization labs, where it helps to optimize hemodynamic stability, manage fluid balance, and monitor patients with cardiovascular diseases or critical illnesses. Hemodynamic monitoring systems typically consist of invasive or non-invasive monitoring devices, sensors, and data processing software, allowing for continuous monitoring and analysis of cardiovascular parameters to support clinical decision-making and improve patient outcomes. The Hemodynamic Monitoring System market is expanding because of factors such as the rising prevalence of cardiovascular and diabetes diseases, the growing number of surgical procedures, and rising integration with Electronic Health Records (EHR) and telemedicine.

As cardiovascular diseases continue to rise globally, there is a growing need for hemodynamic monitoring systems to accurately assess and manage patients' cardiovascular status. According to data from the World Health Organization in 2021, approximately 1.28 billion adults aged 30-79 worldwide are affected by hypertension. Moreover, Cardiovascular diseases (CVDs) stand as the primary cause of mortality globally, claiming an estimated 17.9 million lives annually, constituting approximately 32% of all global deaths. These alarming statistics underscore the significant impact of cardiac disorders and hypertension on public health. Consequently, the prevalence of these conditions is anticipated to drive market growth. In addition, rising healthcare expenditures and rising regulatory approval of medical devices are creating new opportunities for market growth. However, increasing incidences of complications associated with invasive monitoring systems stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Hemodynamic Monitoring System Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 primarily driven by several factors. The substantial presence of major market players, the widespread adoption of cutting-edge technologies in hospitals, and the rising influx of critically ill patients seeking treatment within the region's healthcare facilities are expected to drive regional demand. Furthermore, the United States Food and Drug Administration (FDA) approvals for monitoring devices and the introduction of new products are anticipated to fuel growth in the United States hemodynamic monitoring market throughout the forecast period. For instance, in September 2021, Caretaker Medical received FDA clearance for its blood pressure and hemodynamic patient monitoring system, VitalStream. Similarly, in March 2021, Fifth Eye, a Michigan-based real-time clinical analytics company, revealed that its Analytic for Hemodynamic Instability (AHI) tool had been granted DE Novo classification by the Food and Drug Administration. Asia Pacific is expected to grow at the fastest rate during the forecast period, owing to factors such as heightened emphasis on healthcare expenditure to meet the growing need for sophisticated patient monitoring systems for critically ill individuals is driving market expansion. Additionally, the aging population and governmental efforts to encourage advancements in patient monitoring systems are amplifying the adoption of hemodynamic control systems, thus propelling market growth in the region.

Major market players included in this report are:

• LiDCO Group PLC
• Baxter (Cheetah Medical Inc.)
• ICU Medical Inc.
• Tensys Medical Inc.
• Schwarzer Cardiotek GmbH
• Koninklijke Philips NV
• Edwards Lifesciences Corporation
• Getinge Group
• GE Healthcare
• Draeger Medical

Recent Developments in the Market:

• In October 2023, Masimo obtained CE approval for the LiDCO board-in-cable (BIC) module, enhancing its portfolio of hemodynamic monitoring systems and signaling its commitment to expanding product offerings in this field.
• In April 2022, Caretaker Medical secured FDA approval for a wireless wearable monitor designed for continuous blood pressure monitoring and advanced hemodynamics. This approval strengthens Caretaker Medical's global product portfolio, underscoring its dedication to providing innovative solutions in the healthcare market.

Global Hemodynamic Monitoring System Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - System, Application, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By System:

• Minimally Invasive Monitoring Systems
• Invasive Monitoring Systems
• Non-invasive Monitoring Systems

By Application:

• Laboratory-based Monitoring Systems
• Home-based Monitoring Systems
• Hospital-based Monitoring Systems

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Hemodynamic Monitoring System Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Hemodynamic Monitoring System Market, by System, 2020-2030 (USD Billion)
  • 1.2.3.Hemodynamic Monitoring System Market, by Application, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Hemodynamic Monitoring System Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Hemodynamic Monitoring System Market Dynamics

• 3.1.Hemodynamic Monitoring System Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Rising Prevalence of Cardiovascular and Diabetes Diseases
    • 3.1.1.2.Growing Number of Surgical Procedures
    • 3.1.1.3.Rising Integration with Electronic Health Records (EHR And Telemedicine
  • 3.1.2.Market Challenges
    • 3.1.2.1.Increasing Incidences of Complications Associated with Invasive Monitoring Systems
    • 3.1.2.2.Preference for Non-Invasive Monitoring
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Rising Healthcare Expenditure
    • 3.1.3.2.Rising Regulatory Approval of Medical Devices

Chapter 4.Global Hemodynamic Monitoring System Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Hemodynamic Monitoring System Market, by System

• 5.1.Market Snapshot
• 5.2.Global Hemodynamic Monitoring System Market by System, Performance - Potential Analysis
• 5.3.Global Hemodynamic Monitoring System Market Estimates & Forecasts by System 2020-2030 (USD Billion)
• 5.4.Hemodynamic Monitoring System Market, Sub Segment Analysis
  • 5.4.1. Minimally Invasive Monitoring Systems
  • 5.4.2.Invasive Monitoring Systems
  • 5.4.3.Non-invasive Monitoring Systems

Chapter 6.Global Hemodynamic Monitoring System Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Hemodynamic Monitoring System Market by Application, Performance - Potential Analysis
• 6.3.Global Hemodynamic Monitoring System Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Hemodynamic Monitoring System Market, Sub Segment Analysis
  • 6.4.1. Laboratory-based Monitoring Systems
  • 6.4.2.Home-based Monitoring Systems
  • 6.4.3.Hospital-based Monitoring Systems

Chapter 7.Global Hemodynamic Monitoring System Market, Regional Analysis

• 7.1.Top Leading Countries
• 7.2.Top Emerging Countries
• 7.3.Hemodynamic Monitoring System Market, Regional Market Snapshot
• 7.4.North America Hemodynamic Monitoring System Market
  • 7.4.1.U.S. Hemodynamic Monitoring System Market
    • 7.4.1.1.System breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2.Application breakdown estimates & forecasts, 2020-2030
  • 7.4.2.Canada Hemodynamic Monitoring System Market
• 7.5.Europe Hemodynamic Monitoring System Market Snapshot
  • 7.5.1.U.K. Hemodynamic Monitoring System Market
  • 7.5.2.Germany Hemodynamic Monitoring System Market
  • 7.5.3.France Hemodynamic Monitoring System Market
  • 7.5.4.Spain Hemodynamic Monitoring System Market
  • 7.5.5.Italy Hemodynamic Monitoring System Market
  • 7.5.6.Rest of Europe Hemodynamic Monitoring System Market
• 7.6.Asia-Pacific Hemodynamic Monitoring System Market Snapshot
  • 7.6.1.China Hemodynamic Monitoring System Market
  • 7.6.2.India Hemodynamic Monitoring System Market
  • 7.6.3.Japan Hemodynamic Monitoring System Market
  • 7.6.4.Australia Hemodynamic Monitoring System Market
  • 7.6.5.South Korea Hemodynamic Monitoring System Market
  • 7.6.6.Rest of Asia Pacific Hemodynamic Monitoring System Market
• 7.7.Latin America Hemodynamic Monitoring System Market Snapshot
  • 7.7.1.Brazil Hemodynamic Monitoring System Market
  • 7.7.2.Mexico Hemodynamic Monitoring System Market
• 7.8.Middle East & Africa Hemodynamic Monitoring System Market
  • 7.8.1.Saudi Arabia Hemodynamic Monitoring System Market
  • 7.8.2.South Africa Hemodynamic Monitoring System Market
  • 7.8.3.Rest of Middle East & Africa Hemodynamic Monitoring System Market

Chapter 8.Competitive Intelligence

• 8.1.Key Company SWOT Analysis
• 8.2.Top Market Strategies
• 8.3.Company Profiles
  • 8.3.1. LiDCO Group PLC
    • 8.3.1.1.Key Information
    • 8.3.1.2.Overview
    • 8.3.1.3.Financial (Subject to Data Availability)
    • 8.3.1.4.Product Summary
    • 8.3.1.5.Recent Developments
  • 8.3.2. Baxter (Cheetah Medical Inc.)
  • 8.3.3.ICU Medical Inc.
  • 8.3.4.Tensys Medical Inc.
  • 8.3.5.Schwarzer Cardiotek GmbH
  • 8.3.6.Koninklijke Philips NV
  • 8.3.7.Edwards Lifesciences Corporation
  • 8.3.8.Getinge Group
  • 8.3.9.GE Healthcare
  • 8.3.10.Draeger Medical

Chapter 9.Research Process

• 9.1.Research Process
  • 9.1.1.Data Mining
  • 9.1.2.Analysis
  • 9.1.3.Market Estimation
  • 9.1.4.Validation
  • 9.1.5.Publishing
• 9.2.Research Attributes
• 9.3.Research Assumption